Andrew Elder
InvestorDeputy Managing Partner at AlbionVC Β· General Partner at UCL Technology Fund Β· Visiting Fellow at Zinc Β· Member of Investment Committee (Direct / Co-investment funds) at British Business Investments
London, England, United Kingdom
About
Andrew Elder is a former neurosurgeon who now invests in medical technologies and technology-enabled services for the healthcare and life-science sectors, including digital health, diagnostics and imaging, machine learning applications, and therapeutics such as cell and gene therapies. Before AlbionVC he worked on healthcare strategy at the Boston Consulting Group. He holds degrees in Medicine and Surgery from the University of Cambridge and is a Fellow of the Royal College of Surgeons.
Invests in
AI & Machine LearningBiotechDigital HealthHealthtechMedical Devices
Experience
- AlbionVCPartner at AlbionVC (Deputy Managing Partner)current2019 β present
- AlbionVCPartnercurrent2005 β presentLondon, United Kingdom
- UCL Technology FundGeneral Partnercurrent2016 β present
- Health Data Research UK (HDR UK)Member Board Of Trusteescurrent2022 β present
- British Business BankMember of Investment Committee (Direct / Co-investment funds)current2023 β present
- ZINCVisiting Fellowcurrent2022 β presentLondon
- Future VCVC Mentorcurrent2021 β present
- The Prince's TrustBusiness Mentorcurrent2017 β present
- Flok HealthBoard Membercurrent2026 β presentCambridge
- HealiosBoard Membercurrent2018 β present
- Aridhia β Digital Research Environment β DREBoard Membercurrent2013 β present
- The EvewellBoard Member2017 β 2025
- uMotifBoard Member2018 β 2023
- ABCODIA LIMITEDBoard Member2011 β 2022
- MyMeds&MeBoard Member2013 β 2022(Acq: DSS / Bioclinica)
- DYSIS MedicalBoard Member2009 β 2018
- Masters Speciality PharmaBoard Member2010 β 2017
- Exco InTouch (ePRO; Acq: ERT Inc)Board Member2014 β 2016
- Dexela (Medical Imaging; Acq: Perkin Elmer)Board Member2006 β 2011
- Close VenturesDirector2005 β 2009
- Boston Consulting GroupConsultant2001 β 2005
- NHSNeurosurgeon1995 β 2000
Skills & more
+7 more
Private EquityMergersStrategic PlanningStart-upsValuationStrategyMergers & AcquisitionsFrom Andrew's professional profile.
Deals Β· 1
Exco IntouchLed round
via AlbionVC
Attribution from SEC filings, press coverage, and firm rosters.
Other disclosed investments
Led
Abcodia (AIM)Dexela (Perkin Elmer)MyMeds &Me
Investor
Per the firm's website.
Colleagues at AlbionVC
Frequently asked questions
- Who is Andrew Elder?
- Andrew Elder is a former neurosurgeon who now invests in medical technologies and technology-enabled services for the healthcare and life-science sectors, including digital health, diagnostics and imaging, machine learning applications, and therapeutics such as cell and gene therapies. Before AlbionVC he worked on healthcare strategy at the Boston Consulting Group. He holds degrees in Medicine and Surgery from the University of Cambridge and is a Fellow of the Royal College of Surgeons.
- Where does Andrew Elder work?
- Andrew Elder is Deputy Managing Partner at AlbionVC.
- What does Andrew Elder invest in?
- Andrew Elder invests in AI & Machine Learning, Biotech, Digital Health, Healthtech, Medical Devices.
- What companies has Andrew Elder invested in?
- Investments tracked here include Abcodia (AIM), Dexela (Perkin Elmer), Exco Intouch, MyMeds &Me, Aridhia, CS Genetics, Flok, Healios.
- Where did Andrew Elder go to school?
- Andrew Elder studied at The Royal College of Surgeons of England (FRCS, Surgery); University of Cambridge (MA MB BChir, Medicine); St Paul's School.
- Does Andrew Elder lead rounds?
- Yes β Andrew Elder has led 4 tracked investments.
Same school
Also attended University of Cambridge1,136
+ 1,130 more
Also attended St Paul's School51
+ 45 more
Shared employers
Also worked at DYSIS Medical1
Also worked at Boston Consulting Group1,125
+ 1,119 more
Also worked at NHS41
+ 35 more



























.png)

















